Skip to main content
SpringerLink
Log in

Expression and clinical significance of stem cell marker CD133 in human neuroblastoma

  • Original Article
  • Published:
World Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Background

Recent evidences indicate that CD133, a kind of transmembrane protein, can be used as a marker to isolate stem cells from tumors originating from neural crest. This study was undertaken to explore the expression and clinical significance of stem cell marker CD133 in neuroblastoma (NB).

Methods

Immunohistochemical staining was used to detect the expression of CD133 in 32 patients with NB and 8 patients with ganglioneuroblastoma (GNB). The relationships were analyzed among CD133 expression, international neuroblastoma staging system (INSS) stages, pathological classification, and postoperative survival time of NB patients.

Results

The expression rates of CD133 in NB and GNB were 46.9% (15/32) and 37.5% (3/8) respectively, mainly in cytoplasm of neuroblastoma cells. The expression rates of stage 1–2, stage 3–4 and stage 4S were 30.7%, 57.9% and 37.5%, respectively. The differences in various stages were significant (P<0.05). The positive rate of CD133 in patients with unfavorable histology (52.4%) was significantly higher than that in patients with favorable histology (36.8%) (P=0.007). The survival time of CD133 negative patients was significantly longer than that of CD133 positive patients (P=0.026).

Conclusions

CD133 which might be correlated with the development and progression of NB can serve as one of the important indicators for prognosis of NB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, et al. A distinct “side population” of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 2004;101:14228–14233.

    Article  PubMed  CAS  Google Scholar 

  2. Shmelkov SV, St Clair R, Lyden D, Rafii S. AC133/CD133/Prominin-1. Int J Biochem Cell Biol 2005;37:715–719.

    Article  PubMed  CAS  Google Scholar 

  3. Shimada H, Chatten J, Newton WA Jr, Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405–416.

    PubMed  CAS  Google Scholar 

  4. Yin AH, Miraglia S, Zanjani ED, Bichoff J. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002–5012.

    PubMed  CAS  Google Scholar 

  5. Bhatia M. AC133 expression in human stem cells. Leukemia 2001;15:1685–1688.

    PubMed  CAS  Google Scholar 

  6. Uchida N, Buck DW, He D, Reitsma MJ, Masek M, Phan TV, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000;97:14720–15725.

    Article  PubMed  CAS  Google Scholar 

  7. Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J, et al. Identification of a cancer stem cell in human brain tumours. Cancer Res 2003;63:5821–5828.

    PubMed  CAS  Google Scholar 

  8. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396–401.

    Article  PubMed  CAS  Google Scholar 

  9. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, et al. Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 2006;5:67.

    Article  PubMed  Google Scholar 

  10. Marzi I, D’Amico M, Biagiotti T, Giunti S, Carbone MV, Fredducci D, et al. Purging of the neuroblastoma stem cell compartment and tumor regression on exposure to hypoxia or cytotoxic treatment. Cancer Res 2007;67:2402–2407.

    Article  PubMed  CAS  Google Scholar 

  11. Biagiotti T, D’Amico M, Marzi I, Di Gennar P, Arcangeli A, Wanke E, et al. Cell renewing in neuroblastoma: electrophysiological and immunocytochemical characterization of stem cells and derivatives. Stem Cells 2006;24:443–453.

    Article  PubMed  Google Scholar 

  12. Walton JD, Kattan DR, Thomas SK, Spengler BA, Guo HF, Biedler JL, et al. Characteristics of stem cells from human neuroblastoma cell lines and in tumors. Neoplasia 2004;6:838–845.

    Article  PubMed  Google Scholar 

  13. Hilbe W, Dirnhofer S, Oberwasserlechner F, Schmid T, Gunsilius E, Hilbe G, et al. CD133 positive endothelial progenitor cells contribute to the tumour vasculature in nonsmall cell lung cancer. J Clin Pathol 2004;57:965–969.

    Article  PubMed  CAS  Google Scholar 

  14. Bruno S, Bussolati B, Grange C, Collino F, Graziano ME, Ferrando U, et al. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol 2006;169:2223–2235.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatric Surgery, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Qiang-Song Tong, Shao-Tao Tang, Qing-Lan Ruan, Yuan Liu, Shi-Wang Li, Guo-Song Jiang & Jia-Bin Cai

  2. Department of Pathology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China

    Li-Duan Zheng

Authors
  1. Qiang-Song Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li-Duan Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shao-Tao Tang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qing-Lan Ruan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shi-Wang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Guo-Song Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jia-Bin Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiang-Song Tong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tong, QS., Zheng, LD., Tang, ST. et al. Expression and clinical significance of stem cell marker CD133 in human neuroblastoma. World J Pediatr 4, 58–62 (2008). https://doi.org/10.1007/s12519-008-0012-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12519-008-0012-z

Key words

Search

Navigation